Cargando…
High-grade glioma associated immunosuppression does not prevent immune responses induced by therapeutic vaccines in combination with T(reg) depletion
High-grade gliomas (HGG) exert systemic immunosuppression, which is of particular importance as immunotherapeutic strategies such as therapeutic vaccines are increasingly used to treat HGGs. In a first cohort of 61 HGG patients we evaluated a panel of 30 hematological and 34 plasma biomarkers. Then,...
Autores principales: | Löhr, Mario, Freitag, Benjamin, Technau, Antje, Krauss, Jürgen, Monoranu, Camelia-Maria, Rachor, Johannes, Lutz, Manfred B., Hagemann, Carsten, Kessler, Almuth F., Linsenmann, Thomas, Wölfl, Matthias, Ernestus, Ralf-Ingo, Engelhardt, Sabrina, Gelbrich, Götz, Schlegel, Paul G., Eyrich, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182405/ https://www.ncbi.nlm.nih.gov/pubmed/30054667 http://dx.doi.org/10.1007/s00262-018-2214-0 |
Ejemplares similares
-
IMMU-07. Interim analysis of the HIT-HGG Rez Immunvac study - Dendritic cell vaccination with partial T(reg) depletion and double checkpoint blockade in children with relapsed high-grade gliomas.
por: Eyrich, Matthias, et al.
Publicado: (2022) -
IMMU-10. INTERIM ANALYSIS OF THE HIT-HGG REZ IMMUNVAC STUDY - DENDRITIC CELL VACCINATION WITH PARTIAL TREG DEPLETION IN CHILDREN, ADOLESCENTS, AND ADULTS WITH RELAPSED HIGH-GRADE GLIOMAS
por: Eyrich, Matthias, et al.
Publicado: (2020) -
Circulating MACC1 Transcripts in Glioblastoma Patients Predict Prognosis and Treatment Response
por: Hagemann, Carsten, et al.
Publicado: (2019) -
Long-term tumor control of spinal dissemination of cerebellar glioblastoma multiforme by combined adjuvant bevacizumab antibody therapy: a case report
por: Linsenmann, Thomas, et al.
Publicado: (2014) -
Primary brain amyloidoma, both a neoplastic and a neurodegenerative disease: a case report
por: Löhr, Mario, et al.
Publicado: (2019)